Financial Associated Press (Shanghai, Editor Shi Zhengcheng) News, As U.S. bond yields continued to climb to December 2019 levels before the market opened on Tuesday, coupled with uncertainty about economic growth and monetary policy, the three major futures indexes maintained a weak oscillation state. Technology growth stocks were generally weaker.
While the market began to worry about the ten-year U.S. bond yield rising by 3% this year, the financial reports of stocks failed to bring good news. Although Pfizer, the pharmaceutical leader, has given an expectation that revenue will reach 100 billion US dollars in 2022, it is still slightly lower than Wall Street's expectations, causing the entire vaccine sector to weaken.
Compared with the fluctuations of individual stocks in the industry, the overall market hesitancy is mainly affected by the Ministry of Labor CPI data that will be released later this week. The current expectation is that it will continue to rise to 7.2% year-on-year. Oanda market strategy analyst Edward Moya said that before the latest inflation data reveals how aggressively the Federal Reserve will tighten monetary policy, the U.S. stock market, which is still overvalued, will be in a state of entanglement in the direction of the trend.
At the same time, regarding the continued weakness of technology stocks , Moya also emphasized that investors are currently focusing on valuation, competitive advantages and long-term business prospects.
Market dynamics
As of 21:06 Beijing time, the Dow futures (March 2022 contract) rose 0.13%, S&P 500 index futures fell 0.01%; Nasdaq 100 index futures fell 0.13% .
US stocks experienced a late surge on the previous trading day, dived . As of the close, the S&P 500 index fell 0.37% to close at 4483.87 points; the Nasdaq index fell 0.58% to 14015.67 points; the Dow Jones index closed almost flat, rising slightly by 1.39 points. The European market where
is trading is also in a stalemate situation. Under the influence of the weakness of technology stocks, most major stock indexes are in a state of slight gains and losses.
(Major European stock index conditions on Tuesday, source: Investing)
Company news
[Nvidia and SoftBank announced that the Arm acquisition has failed]
After the market closed on February 7, local time, Nvidia and SoftBank Group issued announcements, announcing that they were unable to obtain supervision. Approved, officially suspending the Arm acquisition. Under the terms of the deal, SoftBank will retain the $1.25 billion in upfront payments Nvidia previously paid and include it in current quarter profits, while Nvidia will retain the Arm license for twenty years.
[Before the "CEO change" drama comes to an end Spotify, Netflix executives take over the Peloton seal]
Peloton (Peloton), a home fitness and content subscription company that has been in trouble recently, announced on Tuesday that the company's founder and CEO John Foley will step down and become executive chairman. Former Spotify and Netflix CFO Barry McCarthy will replace him and join the board of directors.
According to media reports, this change also means that the company will not consider selling to , Amazon, , Nike and other companies in the short term. Foley said the company had long had plans to replace its CEO, and McCarthy only came into view a few weeks ago. The company will subsequently reduce its workforce by 20% to reflect the reduction in orders and reduce losses.
In addition to the management change, Paraten also lowered its revenue guidance for fiscal year 2022 (ending June 30 this year) from US$4.4-4.8 billion to US$3.7-3.8 billion in its financial report released on Tuesday. As of press time, Peloton fell 2.45% before the market opened.
["Silicon Valley Venture Capital Godfather" will withdraw from Meta's board of directors]
On Monday local time, Meta Platforms issued an announcement announcing that Silicon Valley science and technology venture capital star Peter Thiel (Peter Thiel) will withdraw from the board of directors after this year's shareholder meeting. . Peter was also an early investor in the social media giant and the longest-serving outside director on the board. Affected by the withdrawal of well-known directors, Meta fell 1.44% as of press time.
[ BP hits highest profit in eight years]
British Petroleum (BP) announced its financial report on Tuesday, showing that its full-year net profit in 2021 was US$12.85 billion, which was not only better than market expectations, but also the highest since 2013. Profit levels, including a profit of US$4.1 billion in the fourth quarter alone.
In addition to its traditional petrochemical energy business, BP continues to commit to increasing spending on low-carbon and renewable energy to account for 40% of total spending by 2025, and this number will grow to 50% by 2030.
[Pfizer expects new crown vaccine and oral drug revenue to reach US$54 billion in 2022]
Before the market opened on Tuesday, the pharmaceutical giant Pfizer released its fourth quarter and full-year financial reports, of which revenue was US$23.84 billion, slightly lower than the market Expected US$24.12 billion, adjusted net profit of US$6.239 billion, a year-on-year increase of 156%.
In terms of performance guidance, Pfizer expects fiscal year 2022 revenue to be between US$98 billion and US$102 billion, including US$32 billion in revenue from the new crown vaccine (US$36.781 billion in 2021) and US$22 billion in revenue from the new coronavirus oral drug Paxlovid. . However, Pfizer's full-year revenue guidance was also lower than Wall Street's expectations of $104.1 billion. As of press time, Pfizer fell 3% before the market opened.
Affected by Pfizer's lower-than-expected revenue guidance, many vaccine stocks fell simultaneously before the market opened. As of press time, BioNTech fell 3.92%, Moderna fell 3.2%, and Novavax fell 6.5%.
Events worthy of attention during the US stock market period (Beijing time)
html February 821:30 US December trade account
html February 901:00 EIA releases monthly short-term energy outlook report
05:30 US API crude oil for the week to February 4 stock
